nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—F13A1—Common Pathway—SERPIND1—cervical cancer	0.0594	0.266	CbGpPWpGaD
L-Glutamine—F13A1—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.0341	0.153	CbGpPWpGaD
L-Glutamine—F13A1—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.0298	0.134	CbGpPWpGaD
L-Glutamine—TGM4—epithelium—cervical cancer	0.0172	0.0232	CbGeAlD
L-Glutamine—TGM5—endometrium—cervical cancer	0.0107	0.0144	CbGeAlD
L-Glutamine—TGM5—mammalian vulva—cervical cancer	0.0103	0.014	CbGeAlD
L-Glutamine—TGM1—uterine cervix—cervical cancer	0.00956	0.0129	CbGeAlD
L-Glutamine—TGM3—uterine cervix—cervical cancer	0.00896	0.0121	CbGeAlD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00872	0.0391	CbGpPWpGaD
L-Glutamine—TGM1—mammalian vulva—cervical cancer	0.00836	0.0113	CbGeAlD
L-Glutamine—NADSYN1—uterine cervix—cervical cancer	0.00819	0.0111	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00805	0.0361	CbGpPWpGaD
L-Glutamine—TGM5—vagina—cervical cancer	0.00801	0.0108	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00798	0.0358	CbGpPWpGaD
L-Glutamine—TGM3—mammalian vulva—cervical cancer	0.00784	0.0106	CbGeAlD
L-Glutamine—TGM1—female reproductive system—cervical cancer	0.00716	0.00967	CbGeAlD
L-Glutamine—CCBL1—decidua—cervical cancer	0.00716	0.00967	CbGeAlD
L-Glutamine—GLUL—exocrine gland—cervical cancer	0.00711	0.0096	CbGeAlD
L-Glutamine—TGM2—epithelium—cervical cancer	0.00706	0.00954	CbGeAlD
L-Glutamine—GATB—renal system—cervical cancer	0.00703	0.0095	CbGeAlD
L-Glutamine—CCBL1—renal system—cervical cancer	0.00703	0.0095	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00698	0.0313	CbGpPWpGaD
L-Glutamine—CCBL1—endometrium—cervical cancer	0.0068	0.00918	CbGeAlD
L-Glutamine—GLS—renal system—cervical cancer	0.00662	0.00895	CbGeAlD
L-Glutamine—GMPS—uterine cervix—cervical cancer	0.00659	0.00891	CbGeAlD
L-Glutamine—CTPS1—uterine cervix—cervical cancer	0.00659	0.00891	CbGeAlD
L-Glutamine—TGM2—renal system—cervical cancer	0.00655	0.00885	CbGeAlD
L-Glutamine—TGM1—female gonad—cervical cancer	0.00652	0.0088	CbGeAlD
L-Glutamine—TGM1—vagina—cervical cancer	0.00648	0.00875	CbGeAlD
L-Glutamine—PFAS—uterine cervix—cervical cancer	0.00648	0.00875	CbGeAlD
L-Glutamine—GFPT2—uterine cervix—cervical cancer	0.00648	0.00875	CbGeAlD
L-Glutamine—CTPS1—decidua—cervical cancer	0.00628	0.00849	CbGeAlD
L-Glutamine—PFAS—decidua—cervical cancer	0.00617	0.00833	CbGeAlD
L-Glutamine—GFPT2—decidua—cervical cancer	0.00617	0.00833	CbGeAlD
L-Glutamine—GMPS—renal system—cervical cancer	0.00617	0.00833	CbGeAlD
L-Glutamine—CTPS1—renal system—cervical cancer	0.00617	0.00833	CbGeAlD
L-Glutamine—NADSYN1—female reproductive system—cervical cancer	0.00614	0.00829	CbGeAlD
L-Glutamine—GLS2—female reproductive system—cervical cancer	0.00614	0.00829	CbGeAlD
L-Glutamine—TGM3—vagina—cervical cancer	0.00607	0.0082	CbGeAlD
L-Glutamine—GFPT2—renal system—cervical cancer	0.00606	0.00818	CbGeAlD
L-Glutamine—GMPS—endometrium—cervical cancer	0.00596	0.00806	CbGeAlD
L-Glutamine—CTPS1—endometrium—cervical cancer	0.00596	0.00806	CbGeAlD
L-Glutamine—GFPT2—endometrium—cervical cancer	0.00586	0.00791	CbGeAlD
L-Glutamine—PFAS—endometrium—cervical cancer	0.00586	0.00791	CbGeAlD
L-Glutamine—TGM2—uterus—cervical cancer	0.00584	0.00788	CbGeAlD
L-Glutamine—F13A1—uterine cervix—cervical cancer	0.00581	0.00785	CbGeAlD
L-Glutamine—CTPS1—mammalian vulva—cervical cancer	0.00577	0.00779	CbGeAlD
L-Glutamine—GMPS—mammalian vulva—cervical cancer	0.00577	0.00779	CbGeAlD
L-Glutamine—GFPT2—mammalian vulva—cervical cancer	0.00567	0.00765	CbGeAlD
L-Glutamine—PFAS—mammalian vulva—cervical cancer	0.00567	0.00765	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00563	0.0253	CbGpPWpGaD
L-Glutamine—GATB—female reproductive system—cervical cancer	0.00563	0.00761	CbGeAlD
L-Glutamine—GLS2—female gonad—cervical cancer	0.00559	0.00754	CbGeAlD
L-Glutamine—NADSYN1—female gonad—cervical cancer	0.00559	0.00754	CbGeAlD
L-Glutamine—GLS2—vagina—cervical cancer	0.00555	0.0075	CbGeAlD
L-Glutamine—NADSYN1—vagina—cervical cancer	0.00555	0.0075	CbGeAlD
L-Glutamine—F13A1—decidua—cervical cancer	0.00554	0.00748	CbGeAlD
L-Glutamine—QARS—uterine cervix—cervical cancer	0.00552	0.00746	CbGeAlD
L-Glutamine—CTPS1—uterus—cervical cancer	0.0055	0.00742	CbGeAlD
L-Glutamine—F13A1—renal system—cervical cancer	0.00544	0.00734	CbGeAlD
L-Glutamine—GFPT2—uterus—cervical cancer	0.0054	0.00729	CbGeAlD
L-Glutamine—GLS—female reproductive system—cervical cancer	0.00531	0.00716	CbGeAlD
L-Glutamine—QARS—decidua—cervical cancer	0.00526	0.00711	CbGeAlD
L-Glutamine—F13A1—endometrium—cervical cancer	0.00526	0.0071	CbGeAlD
L-Glutamine—TGM2—female reproductive system—cervical cancer	0.00525	0.00709	CbGeAlD
L-Glutamine—QARS—renal system—cervical cancer	0.00517	0.00698	CbGeAlD
L-Glutamine—CCBL1—female gonad—cervical cancer	0.00512	0.00692	CbGeAlD
L-Glutamine—GATB—female gonad—cervical cancer	0.00512	0.00692	CbGeAlD
L-Glutamine—CAD—uterine cervix—cervical cancer	0.00509	0.00688	CbGeAlD
L-Glutamine—CCBL1—vagina—cervical cancer	0.00509	0.00688	CbGeAlD
L-Glutamine—GATB—vagina—cervical cancer	0.00509	0.00688	CbGeAlD
L-Glutamine—F13A1—mammalian vulva—cervical cancer	0.00508	0.00687	CbGeAlD
L-Glutamine—QARS—endometrium—cervical cancer	0.005	0.00675	CbGeAlD
L-Glutamine—CTPS1—female reproductive system—cervical cancer	0.00494	0.00667	CbGeAlD
L-Glutamine—GMPS—female reproductive system—cervical cancer	0.00494	0.00667	CbGeAlD
L-Glutamine—CAD—decidua—cervical cancer	0.00485	0.00655	CbGeAlD
L-Glutamine—GFPT2—female reproductive system—cervical cancer	0.00485	0.00655	CbGeAlD
L-Glutamine—PFAS—female reproductive system—cervical cancer	0.00485	0.00655	CbGeAlD
L-Glutamine—F13A1—uterus—cervical cancer	0.00484	0.00654	CbGeAlD
L-Glutamine—QARS—mammalian vulva—cervical cancer	0.00483	0.00653	CbGeAlD
L-Glutamine—GLS—female gonad—cervical cancer	0.00483	0.00652	CbGeAlD
L-Glutamine—GLS—vagina—cervical cancer	0.0048	0.00648	CbGeAlD
L-Glutamine—TGM2—female gonad—cervical cancer	0.00477	0.00645	CbGeAlD
L-Glutamine—PPAT—uterine cervix—cervical cancer	0.00472	0.00638	CbGeAlD
L-Glutamine—CAD—endometrium—cervical cancer	0.00461	0.00622	CbGeAlD
L-Glutamine—QARS—uterus—cervical cancer	0.0046	0.00622	CbGeAlD
L-Glutamine—GMPS—female gonad—cervical cancer	0.0045	0.00607	CbGeAlD
L-Glutamine—CTPS1—female gonad—cervical cancer	0.0045	0.00607	CbGeAlD
L-Glutamine—CTPS1—vagina—cervical cancer	0.00447	0.00603	CbGeAlD
L-Glutamine—GMPS—vagina—cervical cancer	0.00447	0.00603	CbGeAlD
L-Glutamine—CAD—mammalian vulva—cervical cancer	0.00446	0.00602	CbGeAlD
L-Glutamine—PFAS—female gonad—cervical cancer	0.00442	0.00596	CbGeAlD
L-Glutamine—GFPT2—female gonad—cervical cancer	0.00442	0.00596	CbGeAlD
L-Glutamine—SLC1A5—epithelium—cervical cancer	0.00441	0.00596	CbGeAlD
L-Glutamine—PFAS—vagina—cervical cancer	0.00439	0.00593	CbGeAlD
L-Glutamine—GFPT2—vagina—cervical cancer	0.00439	0.00593	CbGeAlD
L-Glutamine—SLC1A5—uterine cervix—cervical cancer	0.00437	0.00591	CbGeAlD
L-Glutamine—F13A1—female reproductive system—cervical cancer	0.00435	0.00588	CbGeAlD
L-Glutamine—PPAT—endometrium—cervical cancer	0.00427	0.00577	CbGeAlD
L-Glutamine—CAD—uterus—cervical cancer	0.00425	0.00573	CbGeAlD
L-Glutamine—TGM1—lymph node—cervical cancer	0.00419	0.00566	CbGeAlD
L-Glutamine—SLC1A5—decidua—cervical cancer	0.00417	0.00563	CbGeAlD
L-Glutamine—QARS—female reproductive system—cervical cancer	0.00414	0.00559	CbGeAlD
L-Glutamine—PPAT—mammalian vulva—cervical cancer	0.00413	0.00558	CbGeAlD
L-Glutamine—F13A1—Hemostasis—GP6—cervical cancer	0.00412	0.0185	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—SERPIND1—cervical cancer	0.00412	0.0185	CbGpPWpGaD
L-Glutamine—SLC1A5—renal system—cervical cancer	0.00409	0.00553	CbGeAlD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00403	0.0181	CbGpPWpGaD
L-Glutamine—F13A1—female gonad—cervical cancer	0.00396	0.00535	CbGeAlD
L-Glutamine—SLC1A5—endometrium—cervical cancer	0.00396	0.00534	CbGeAlD
L-Glutamine—F13A1—vagina—cervical cancer	0.00394	0.00532	CbGeAlD
L-Glutamine—SLC1A5—mammalian vulva—cervical cancer	0.00383	0.00517	CbGeAlD
L-Glutamine—CAD—female reproductive system—cervical cancer	0.00382	0.00515	CbGeAlD
L-Glutamine—QARS—female gonad—cervical cancer	0.00377	0.00508	CbGeAlD
L-Glutamine—ASNS—uterine cervix—cervical cancer	0.00375	0.00507	CbGeAlD
L-Glutamine—SLC7A8—decidua—cervical cancer	0.00375	0.00507	CbGeAlD
L-Glutamine—QARS—vagina—cervical cancer	0.00374	0.00505	CbGeAlD
L-Glutamine—SLC7A8—renal system—cervical cancer	0.00368	0.00498	CbGeAlD
L-Glutamine—SLC1A5—uterus—cervical cancer	0.00365	0.00492	CbGeAlD
L-Glutamine—F13A1—Hemostasis—GP5—cervical cancer	0.0036	0.0161	CbGpPWpGaD
L-Glutamine—GLS2—lymph node—cervical cancer	0.00359	0.00485	CbGeAlD
L-Glutamine—NADSYN1—lymph node—cervical cancer	0.00359	0.00485	CbGeAlD
L-Glutamine—ASNS—decidua—cervical cancer	0.00358	0.00483	CbGeAlD
L-Glutamine—PPAT—female reproductive system—cervical cancer	0.00354	0.00478	CbGeAlD
L-Glutamine—CAD—female gonad—cervical cancer	0.00347	0.00469	CbGeAlD
L-Glutamine—CAD—vagina—cervical cancer	0.00345	0.00466	CbGeAlD
L-Glutamine—ASNS—endometrium—cervical cancer	0.00339	0.00458	CbGeAlD
L-Glutamine—CCBL1—lymph node—cervical cancer	0.00329	0.00445	CbGeAlD
L-Glutamine—GATB—lymph node—cervical cancer	0.00329	0.00445	CbGeAlD
L-Glutamine—Rigors—Topotecan—cervical cancer	0.00329	0.0949	CcSEcCtD
L-Glutamine—ASNS—mammalian vulva—cervical cancer	0.00328	0.00443	CbGeAlD
L-Glutamine—SLC1A5—female reproductive system—cervical cancer	0.00328	0.00443	CbGeAlD
L-Glutamine—PPAT—female gonad—cervical cancer	0.00322	0.00435	CbGeAlD
L-Glutamine—PPAT—vagina—cervical cancer	0.0032	0.00432	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.00318	0.0142	CbGpPWpGaD
L-Glutamine—ASNS—uterus—cervical cancer	0.00313	0.00422	CbGeAlD
L-Glutamine—GLS—lymph node—cervical cancer	0.0031	0.00419	CbGeAlD
L-Glutamine—GLUL—epithelium—cervical cancer	0.00309	0.00417	CbGeAlD
L-Glutamine—GLUL—uterine cervix—cervical cancer	0.00307	0.00414	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TERT—cervical cancer	0.00306	0.0137	CbGpPWpGaD
L-Glutamine—SLC1A5—female gonad—cervical cancer	0.00298	0.00403	CbGeAlD
L-Glutamine—SLC1A5—vagina—cervical cancer	0.00296	0.004	CbGeAlD
L-Glutamine—SLC7A8—female reproductive system—cervical cancer	0.00295	0.00399	CbGeAlD
L-Glutamine—GLUL—decidua—cervical cancer	0.00292	0.00394	CbGeAlD
L-Glutamine—CTPS1—lymph node—cervical cancer	0.00289	0.0039	CbGeAlD
L-Glutamine—GMPS—lymph node—cervical cancer	0.00289	0.0039	CbGeAlD
L-Glutamine—GLUL—renal system—cervical cancer	0.00287	0.00387	CbGeAlD
L-Glutamine—PFAS—lymph node—cervical cancer	0.00284	0.00383	CbGeAlD
L-Glutamine—GFPT2—lymph node—cervical cancer	0.00284	0.00383	CbGeAlD
L-Glutamine—GLUL—endometrium—cervical cancer	0.00277	0.00374	CbGeAlD
L-Glutamine—SLC7A8—female gonad—cervical cancer	0.00269	0.00363	CbGeAlD
L-Glutamine—GLUL—mammalian vulva—cervical cancer	0.00268	0.00362	CbGeAlD
L-Glutamine—SLC7A8—vagina—cervical cancer	0.00267	0.0036	CbGeAlD
L-Glutamine—ASNS—female gonad—cervical cancer	0.00256	0.00346	CbGeAlD
L-Glutamine—GLUL—uterus—cervical cancer	0.00255	0.00345	CbGeAlD
L-Glutamine—F13A1—lymph node—cervical cancer	0.00255	0.00344	CbGeAlD
L-Glutamine—ASNS—vagina—cervical cancer	0.00254	0.00343	CbGeAlD
L-Glutamine—QARS—lymph node—cervical cancer	0.00242	0.00327	CbGeAlD
L-Glutamine—SLC7A8—Hemostasis—SERPIND1—cervical cancer	0.00236	0.0106	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—GP6—cervical cancer	0.00236	0.0106	CbGpPWpGaD
L-Glutamine—SLC16A10—epithelium—cervical cancer	0.00236	0.00318	CbGeAlD
L-Glutamine—Sepsis—Topotecan—cervical cancer	0.00233	0.0672	CcSEcCtD
L-Glutamine—GLUL—female reproductive system—cervical cancer	0.0023	0.0031	CbGeAlD
L-Glutamine—CAD—lymph node—cervical cancer	0.00223	0.00302	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—cervical cancer	0.00214	0.00959	CbGpPWpGaD
L-Glutamine—GLUL—female gonad—cervical cancer	0.00209	0.00282	CbGeAlD
L-Glutamine—GLUL—vagina—cervical cancer	0.00208	0.0028	CbGeAlD
L-Glutamine—PPAT—lymph node—cervical cancer	0.00207	0.0028	CbGeAlD
L-Glutamine—SLC7A8—Hemostasis—GP5—cervical cancer	0.00207	0.00927	CbGpPWpGaD
L-Glutamine—SLC16A10—mammalian vulva—cervical cancer	0.00204	0.00276	CbGeAlD
L-Glutamine—SLC1A5—lymph node—cervical cancer	0.00192	0.00259	CbGeAlD
L-Glutamine—L-Methionine—MTHFR—cervical cancer	0.00188	1	CrCbGaD
L-Glutamine—SLC16A10—female reproductive system—cervical cancer	0.00175	0.00236	CbGeAlD
L-Glutamine—SLC7A8—lymph node—cervical cancer	0.00173	0.00233	CbGeAlD
L-Glutamine—ASNS—lymph node—cervical cancer	0.00164	0.00222	CbGeAlD
L-Glutamine—SLC16A10—vagina—cervical cancer	0.00158	0.00214	CbGeAlD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CASP8—cervical cancer	0.00151	0.00678	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Topotecan—cervical cancer	0.00147	0.0425	CcSEcCtD
L-Glutamine—Rhinitis—Topotecan—cervical cancer	0.00135	0.039	CcSEcCtD
L-Glutamine—GLUL—lymph node—cervical cancer	0.00134	0.00181	CbGeAlD
L-Glutamine—Pharyngitis—Topotecan—cervical cancer	0.00134	0.0386	CcSEcCtD
L-Glutamine—NADSYN1—Disease—WNT2—cervical cancer	0.00124	0.00558	CbGpPWpGaD
L-Glutamine—Angiopathy—Topotecan—cervical cancer	0.00122	0.0353	CcSEcCtD
L-Glutamine—Chills—Topotecan—cervical cancer	0.00121	0.0349	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CA9—cervical cancer	0.00121	0.00541	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—RARB—cervical cancer	0.00118	0.00527	CbGpPWpGaD
L-Glutamine—Malnutrition—Topotecan—cervical cancer	0.00117	0.0339	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—cervical cancer	0.00116	0.00522	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.00114	0.00513	CbGpPWpGaD
L-Glutamine—Back pain—Topotecan—cervical cancer	0.00114	0.0328	CcSEcCtD
L-Glutamine—Ill-defined disorder—Topotecan—cervical cancer	0.00109	0.0314	CcSEcCtD
L-Glutamine—CCBL1—Disease—WNT2—cervical cancer	0.00109	0.00487	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CA9—cervical cancer	0.00108	0.00482	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CA9—cervical cancer	0.00108	0.00482	CbGpPWpGaD
L-Glutamine—Malaise—Topotecan—cervical cancer	0.00106	0.0306	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—cervical cancer	0.00102	0.00138	CbGeAlD
L-Glutamine—Arthralgia—Topotecan—cervical cancer	0.000999	0.0288	CcSEcCtD
L-Glutamine—Chest pain—Topotecan—cervical cancer	0.000999	0.0288	CcSEcCtD
L-Glutamine—Myalgia—Topotecan—cervical cancer	0.000999	0.0288	CcSEcCtD
L-Glutamine—Discomfort—Topotecan—cervical cancer	0.000987	0.0285	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CA9—cervical cancer	0.000983	0.00441	CbGpPWpGaD
L-Glutamine—Infection—Topotecan—cervical cancer	0.000952	0.0275	CcSEcCtD
L-Glutamine—NADSYN1—Disease—WNT5A—cervical cancer	0.000942	0.00423	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Topotecan—cervical cancer	0.000926	0.0267	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000873	0.0252	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—CA9—cervical cancer	0.00086	0.00385	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CA9—cervical cancer	0.00086	0.00385	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CA9—cervical cancer	0.00086	0.00385	CbGpPWpGaD
L-Glutamine—Fatigue—Topotecan—cervical cancer	0.000826	0.0238	CcSEcCtD
L-Glutamine—CCBL1—Disease—WNT5A—cervical cancer	0.000824	0.00369	CbGpPWpGaD
L-Glutamine—Constipation—Topotecan—cervical cancer	0.000819	0.0236	CcSEcCtD
L-Glutamine—Pain—Topotecan—cervical cancer	0.000819	0.0236	CcSEcCtD
L-Glutamine—Feeling abnormal—Topotecan—cervical cancer	0.000789	0.0228	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Topotecan—cervical cancer	0.000783	0.0226	CcSEcCtD
L-Glutamine—QARS—Gene Expression—NOTCH2—cervical cancer	0.000779	0.00349	CbGpPWpGaD
L-Glutamine—Abdominal pain—Topotecan—cervical cancer	0.000757	0.0219	CcSEcCtD
L-Glutamine—Body temperature increased—Topotecan—cervical cancer	0.000757	0.0219	CcSEcCtD
L-Glutamine—Hypersensitivity—Topotecan—cervical cancer	0.000706	0.0204	CcSEcCtD
L-Glutamine—CAD—Metabolism—CA9—cervical cancer	0.000693	0.00311	CbGpPWpGaD
L-Glutamine—Asthenia—Topotecan—cervical cancer	0.000687	0.0198	CcSEcCtD
L-Glutamine—Pruritus—Topotecan—cervical cancer	0.000678	0.0196	CcSEcCtD
L-Glutamine—PPAT—Metabolism—CA9—cervical cancer	0.000634	0.00284	CbGpPWpGaD
L-Glutamine—Dizziness—Topotecan—cervical cancer	0.000634	0.0183	CcSEcCtD
L-Glutamine—Vomiting—Topotecan—cervical cancer	0.000609	0.0176	CcSEcCtD
L-Glutamine—Rash—Topotecan—cervical cancer	0.000604	0.0174	CcSEcCtD
L-Glutamine—Dermatitis—Topotecan—cervical cancer	0.000604	0.0174	CcSEcCtD
L-Glutamine—Headache—Topotecan—cervical cancer	0.0006	0.0173	CcSEcCtD
L-Glutamine—Nausea—Topotecan—cervical cancer	0.000569	0.0164	CcSEcCtD
L-Glutamine—NADSYN1—Disease—HES1—cervical cancer	0.000542	0.00243	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CA9—cervical cancer	0.000494	0.00221	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CA9—cervical cancer	0.000494	0.00221	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—MTHFR—cervical cancer	0.00049	0.0022	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—NOTCH1—cervical cancer	0.000482	0.00216	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTHFR—cervical cancer	0.000476	0.00214	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TERT—cervical cancer	0.000475	0.00213	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HES1—cervical cancer	0.000474	0.00213	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—MTHFR—cervical cancer	0.000436	0.00196	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—MTHFR—cervical cancer	0.000436	0.00196	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FGFR3—cervical cancer	0.000436	0.00196	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTHFR—cervical cancer	0.000416	0.00187	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TERT—cervical cancer	0.000415	0.00186	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—cervical cancer	0.000411	0.00184	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOTCH1—cervical cancer	0.000409	0.00184	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—MTHFR—cervical cancer	0.000399	0.00179	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGFR3—cervical cancer	0.000381	0.00171	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOTCH1—cervical cancer	0.000358	0.0016	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MTHFR—cervical cancer	0.000349	0.00156	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MTHFR—cervical cancer	0.000349	0.00156	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—MTHFR—cervical cancer	0.000349	0.00156	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—cervical cancer	0.00031	0.00139	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTOR—cervical cancer	0.000307	0.00138	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—cervical cancer	0.000306	0.00137	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—MTHFR—cervical cancer	0.000281	0.00126	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—cervical cancer	0.000272	0.00122	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTOR—cervical cancer	0.000268	0.0012	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—cervical cancer	0.000268	0.0012	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MTHFR—cervical cancer	0.000257	0.00115	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—cervical cancer	0.000238	0.00107	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—cervical cancer	0.000237	0.00106	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—cervical cancer	0.000222	0.000995	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—cervical cancer	0.000215	0.000966	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—cervical cancer	0.000207	0.000929	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTHFR—cervical cancer	0.0002	0.000898	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTHFR—cervical cancer	0.0002	0.000898	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—cervical cancer	0.000188	0.000845	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—cervical cancer	0.000178	0.000798	CbGpPWpGaD
